MENLO PARK, Calif. and SEOUL, South Korea, Oct. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that its ...
MENLO PARK, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a significant advancement for global ...
Organization's 6,000-genome effort will power global ALS research through detailed long-read sequencing data made freely available to scientists worldwide ALS is a progressive neurodegenerative ...
PacBio announced a key study published in the American Journal of Human Genetics by Radboud University Medical Center, showcasing the effectiveness of its HiFi long-read sequencing technology for ...
PacBio PACB recently announced a strategic collaboration with Chulalongkorn University, one of Thailand’s foremost institutions in genomic and translational research, to implement PacBio’s HiFi whole ...
MENLO PARK, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the Vega™ system, the company’s first ...
MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the ...